STOCK TITAN

Clorox (NYSE: CLX) EVP awarded 26,324 restricted stock units

Filing Impact
(Very High)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Hilt Angela C reported acquisition or exercise transactions in this Form 4 filing.

CLOROX CO executive Angela C. Hilt, EVP and Chief Legal Officer, received a grant of 26,324 shares of common stock on June 17, 2026, reported at $94.97 per share as a compensation award. These are in the form of Restricted Stock Units that will vest in full on June 17, 2029.

Following the award, she holds 56,111 common shares directly and 657.357 shares indirectly through a 401(k) plan. This filing reflects an equity compensation grant rather than an open‑market purchase or sale.

Positive

  • None.

Negative

  • None.
Insider Hilt Angela C
Role EVP - Chief Legal Officer
Type Security Shares Price Value
Grant/Award Common Stock 26,324 $94.97 $2.50M
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 56,111 shares (Direct, null); Common Stock — 657.357 shares (Indirect, By 401(k))
Footnotes (1)
  1. [object Object]
Equity grant size 26,324 shares Common Stock grant on June 17, 2026
Grant valuation price $94.97 per share Reported price for the 26,324-share award
Direct holdings after grant 56,111 shares Total Clorox common shares held directly post-transaction
Indirect 401(k) holdings 657.357 shares Clorox common shares held indirectly via 401(k)
RSU vesting date June 17, 2029 Restricted Stock Units vest in full on this date
Restricted Stock Units financial
"The Restricted Stock Units will vest in full on the third anniversary"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
401(k) financial
"direct_or_indirect: I, nature_of_ownership: By 401(k)"
A 401(k) is a type of retirement savings plan offered by employers that allows workers to set aside a portion of their paycheck before taxes are taken out. The money saved in a 401(k) can grow over time through investments, helping individuals build funds for their future retirement. It matters to investors because it provides a tax-advantaged way to save and invest for long-term financial security.
grant date financial
"on the third anniversary of the grant date, June 17, 2029"
The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hilt Angela C

(Last)(First)(Middle)
1221 BROADWAY

(Street)
OAKLAND CALIFORNIA 94612-1888

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
CLOROX CO /DE/ [ CLX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP - Chief Legal Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/17/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/17/2026A(1)26,324A$94.9756,111D
Common Stock657.357IBy 401(k)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The Restricted Stock Units will vest in full on the third anniversary of the grant date, June 17, 2029.
By Jinho Joo, Attorney-in-Fact06/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Clorox (CLX) executive Angela Hilt report in this Form 4?

Angela C. Hilt reported receiving 26,324 Clorox common shares as a compensation grant. The award is structured as Restricted Stock Units, with the transaction priced at $94.97 per share and increasing her direct ownership to 56,111 shares after the grant.

Is Angela Hilt’s Clorox (CLX) transaction an open-market buy or a grant?

The transaction is a grant, not an open-market purchase. Angela Hilt received 26,324 Clorox common shares as a compensation-related award, identified as a grant or other acquisition under code A, with no indication of a discretionary market trade.

When do Angela Hilt’s Clorox (CLX) Restricted Stock Units vest?

The Restricted Stock Units tied to this award vest in full on June 17, 2029. This means Angela Hilt’s right to the underlying Clorox shares becomes fully earned on that date, assuming any applicable service or other vesting conditions are satisfied.

How many Clorox (CLX) shares does Angela Hilt own after this filing?

After the reported grant, Angela Hilt holds 56,111 Clorox common shares directly. She also has an additional 657.357 Clorox shares held indirectly through a 401(k) plan, giving a combined reported position across direct and indirect holdings in this filing.

What price per share is reported for Angela Hilt’s Clorox (CLX) grant?

The filing lists a price of $94.97 per share for the 26,324 granted Clorox common shares. This figure reflects the valuation used for the grant on the transaction date, not an executed open-market purchase price or a sale price.